Skip to Main Content

Paper Details

Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.
Nat Genet
119
2016
CDH1, CDH1 gene, Cas9, Plasmacytoid, Plasmacytoid bladder cancer, bladder cancer, bladder cancer cells, plasmacytoid, plasmacytoid carcinomas, plasmacytoid variant bladder cancer
Author NameAffiliation
Rohit MehraUniversity of Michigan Health System ann arbor
Neil B DesaiMemorial Sloan Kettering Cancer Center
Anuradha GopalanMemorial Sloan Kettering Cancer Center
Agnes VialeMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Michael F BergerMemorial Sloan Kettering Cancer Center
Michael F BergerMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Victor E ReuterMemorial Sloan Kettering Cancer Center
Victor E ReuterWeill Cornell Medical College, Cornell University
Barry S TaylorMemorial Sloan Kettering Cancer Center
Barry S TaylorMemorial Sloan Kettering Cancer Center
Barry S TaylorMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Barry S TaylorMemorial Sloan Kettering Cancer Center
Barry S TaylorMemorial Sloan Kettering Cancer Center
Barry S TaylorMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
  • 1 - 14

Datasets

Release 1.2